Multinational pharmaceutical firm Mylan has announced it will invest $1 billion on capital expenditure in India in the next five-six years. Adding that each year it has invested $400-450 million towards capex, half of which was invested in India, Mylan called for the government to incentivise research and development in the sector. In 2007, Mylan had acquired Hyderabad-based Matrix Laboratories.